EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA)Turck, DominiqueCastenmiller, JacquelineDe Henauw, StefaanHirsch-Ernst, Karen IldicoKearney, JohnMaciuk, AlexandreMangelsdorf, IngeMcArdle, Harry JNaska, AndronikiPelaez, CarmenPentieva, KristinaSiani, AlfonsoThies, FrankTsabouri, SophiaVinceti, MarcoCubadda, FrancescoFrenzel, ThomasHeinonen, MarinaMarchelli, RosangelaNeuhauser-Berthold, MonikaPoulsen, MortenPrieto Maradona, MiguelSchlatter, Josef Rudolfvan Loveren, HenkRoldán-Torres, RuthKnutsen, Helle Katrine2021-05-062021-05-062021-04-08EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck, D, Castenmiller, J, De Henauw, S, Hirsch-Ernst, K I, Kearney, J, Maciuk, A, Mangelsdorf, I, McArdle, H J, Naska, A, Pelaez, C, Pentieva, K, Siani, A, Thies, F, Tsabouri, S, Vinceti, M, Cubadda, F, Frenzel, T, Heinonen, M, Marchelli, R, Neuhauser-Berthold, M, Poulsen, M, Prieto Maradona, M, Schlatter, J R, van Loveren, H, Roldán-Torres, R & Knutsen, H K 2021, 'Safety of Vitamin D2 mushroom powder (Agaricus bisporus) as a Novel food pursuant to Regulation (EU) 2015/2283', EFSA Journal, vol. 19, no. 4, e06516. https://doi.org/10.2903/j.efsa.2021.65161831-4732PubMedCentral: PMC8028285ORCID: /0000-0002-9275-9713/work/99981941https://hdl.handle.net/2164/16396Acknowledgements: The Panel wishes to thank Petra Gergelova for the support provided to this scientific opinion.192067502engnovel foodsafetyAgaricus bisporus mushroom powderingredientfood supplementvitamin D2UVR MedicineRJournal article10.2903/j.efsa.2021.6516194